tungstate has been researched along with Obesity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barcelo-Batllori, S; Canals, I; Claret, M; Corominola, H; Gomis, R; Guinovart, JJ; Saura, J | 1 |
Barceló-Batllori, S; Canals, I; Claret, M; Corominola, H; Gomis, R; Guinovart, J | 1 |
Barberà, A; Domínguez, J; Fernàndez-Alvarez, J; Gomis, R; Guinovart, JJ; Muñoz, MC | 1 |
3 other study(ies) available for tungstate and Obesity
Article | Year |
---|---|
Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation.
Topics: Adipose Tissue; Administration, Oral; Animals; Anti-Obesity Agents; Body Temperature Regulation; Male; Membrane Microdomains; Obesity; Rats; Rats, Wistar; Tungsten Compounds; Weight Gain | 2005 |
Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Lipid Metabolism; Male; Obesity; Proteome; Rats; Rats, Wistar; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tungsten Compounds; Up-Regulation; Weight Gain | 2005 |
Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus; Glucose-6-Phosphate; Glycogen; Hyperglycemia; Hypoglycemic Agents; Islets of Langerhans; Liver; Male; Obesity; Phosphorylation; Rats; Rats, Zucker; Tungsten Compounds; Tyrosine | 2001 |